Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
2.440
+0.065 (2.75%)
Jul 16, 2025, 3:01 PM EDT
Raia Drogasil Revenue
Raia Drogasil had revenue of 10.05B BRL in the quarter ending March 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 39.81B, up 13.29% year-over-year. In the year 2024, Raia Drogasil had annual revenue of 38.86B with 14.40% growth.
Revenue (ttm)
39.81B BRL
Revenue Growth
+13.29%
P/S Ratio
0.59
Revenue / Employee
614.83K BRL
Employees
64,758
Market Cap
4.12B USD
Revenue Chart
* This company reports financials in BRL.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Raia Drogasil News
- 2 months ago - Raia Drogasil: Valuation Burn Now, Healthy Gains Later - Seeking Alpha
- 4 months ago - Raia Drogasil SA (RADLY) Q4 2024 Earnings Call Highlights: Expansion and Digital Growth Amid ... - GuruFocus
- 7 months ago - Raia Drogasil S.A. goes ex dividend tomorrow - Seeking Alpha
- 9 months ago - Raia Drogasil goes ex dividend tomorrow - Seeking Alpha